MORF News
Archived Headlines
- US IPO Week Ahead: Tech and big biotech fill up a 9-IPO week 06/21/19
- June is getting a flood of biotech IPOs with these 9 deals on the calendar 06/18/19
- Chronic disease biotech Morphic Holding sets terms for $75 million IPO 06/14/19
- Chronic disease biotech Morphic Holding files for an $86 million IPO 05/30/19
US IPO Week Ahead: The IPO market takes its holiday vacation
There are no companies scheduled for the holiday week ahead, and we likely won’t see any more IPOs until 2020. Lock-up periods will be expiring for seven companies. On Monday, December 23: Cambium Networks (CMBM). On Tuesday,...read more
US IPO Weekly Recap: Big biotechs score big as Adaptive soars 142%
Eight companies raised $2.1 billion this past week, capping off the US IPO market's largest quarter in five years. The week was split between tech and biotechs, including two in the biotech space that went public at valuations of more than $2.0 billion. Over 10...read more
Morphic Holding prices upsized IPO at $15 midpoint
Morphic Holding, a preclinical biotech developing oral integrin inhibitors for chronic diseases, raised $90 million by offering 6 million shares at $15, within the range of $14 to $16. The company originally planned to sell 5 million shares. Morphic Holding...read more
June's flood of biotech IPOs continues with these 4 deals
June is seeing a wave of biotech IPOs. Five priced last week, and four more are on ...read more